Helicore

IN THE PRESS

Press Releases

Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity

March 26, 2025

·

3 min read

Press Releases

Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions

January 28, 2025

·

4 min read

Business

Helicor Announces Scientific Advisory Board

June 25, 2007

·

1 min read

JOBS